Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Price to Earnings (P/E)
since 2005

Microsoft Excel

Paying user area

Try for free

Abiomed Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Abiomed Inc., P/E, long-term trends, calculation

Microsoft Excel
P/E = Share price1, 2, 3 ÷ Earnings per share1 (EPS) EPS1 = Net income (loss)1
(in thousands)		 ÷ No. shares of common stock outstanding2
May 20, 2022 = ÷ = ÷
May 21, 2021 = ÷ = ÷
May 21, 2020 = ÷ = ÷
May 23, 2019 = ÷ = ÷
May 24, 2018 = ÷ = ÷
May 25, 2017 = ÷ = ÷
May 26, 2016 = ÷ = ÷
May 28, 2015 = ÷ = ÷
May 28, 2014 = ÷ = ÷
May 28, 2013 = ÷ = ÷
Jun 4, 2012 = ÷ = ÷
Jun 2, 2011 = ÷ = ÷
Jun 8, 2010 = ÷ = ÷
Jun 8, 2009 = ÷ = ÷
Jun 16, 2008 = ÷ = ÷
Jun 13, 2007 = ÷ = ÷
Jun 14, 2006 = ÷ = ÷
Jun 14, 2005 = ÷ = ÷

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Abiomed Inc. Annual Report.

The financial data reveals notable developments in share price, earnings per share (EPS), and price-to-earnings (P/E) ratios over the seventeen-year period under review.

Share Price
The share price demonstrates considerable volatility with an overall upward trajectory. Initial years show moderate fluctuations between approximately $7.43 and $22.17 until 2014. From 2014 onward, a significant increase is observed, peaking notably in 2018 at $394.46. Following this peak, the share price declined substantially, settling around $235.75 by 2022. This pattern indicates periods of both rapid investor optimism and subsequent corrections.
Earnings Per Share (EPS)
EPS figures indicate a transition from consistent losses in earlier years (2005-2007) toward profitability starting around 2011. The early financial difficulties are evidenced by negative EPS values reaching as low as -$1.24. A positive EPS emerges in 2012 and generally trends upward with some fluctuations. Significant increases are observed in 2015 at $2.72 and in 2019 at $5.74, illustrating improved operational performance. However, the most recent years show a slight decrease, declining to $3.00 by 2022.
Price-to-Earnings (P/E) Ratio
The P/E ratio is absent in early periods due to negative or negligible earnings. From 2013 onwards, it becomes available and varies widely. Initially, the P/E is very high, for example, 520.81 in 2013, reflecting low earnings relative to share price. Subsequent years feature fluctuations between roughly 22 and 156, indicating varying investor expectations and market sentiments. The P/E ratio remains elevated throughout, which may suggest high investor confidence in future growth despite earnings volatility.

In summary, the data depicts an evolution from an unprofitable phase with low and volatile share prices toward a phase characterized by substantial growth in share price and earnings, albeit accompanied by considerable valuation fluctuations. The high and volatile P/E ratios in later years emphasize speculative components or anticipated future growth embedded in the market valuation.

Comparison to Competitors

Abiomed Inc., P/E, long-term trends, comparison to competitors

Microsoft Excel
Abiomed Inc. Abbott Laboratories CVS Health Corp. Elevance Health Inc. Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc.
May 20, 2022
May 21, 2021
May 21, 2020
May 23, 2019
May 24, 2018
May 25, 2017
May 26, 2016
May 28, 2015
May 28, 2014
May 28, 2013
Jun 4, 2012
Jun 2, 2011
Jun 8, 2010
Jun 8, 2009
Jun 16, 2008
Jun 13, 2007
Jun 14, 2006
Jun 14, 2005

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).

Comparison to Sector (Health Care Equipment & Services)

Abiomed Inc., P/E, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel
Abiomed Inc. Health Care Equipment & Services
May 20, 2022
May 21, 2021
May 21, 2020
May 23, 2019
May 24, 2018
May 25, 2017
May 26, 2016
May 28, 2015
May 28, 2014
May 28, 2013
Jun 4, 2012
Jun 2, 2011
Jun 8, 2010
Jun 8, 2009
Jun 16, 2008
Jun 13, 2007
Jun 14, 2006
Jun 14, 2005

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).

Comparison to Industry (Health Care)

Abiomed Inc., P/E, long-term trends, comparison to industry (health care)

Microsoft Excel
Abiomed Inc. Health Care
May 20, 2022
May 21, 2021
May 21, 2020
May 23, 2019
May 24, 2018
May 25, 2017
May 26, 2016
May 28, 2015
May 28, 2014
May 28, 2013
Jun 4, 2012
Jun 2, 2011
Jun 8, 2010
Jun 8, 2009
Jun 16, 2008
Jun 13, 2007
Jun 14, 2006
Jun 14, 2005

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).